The PPAR signaling pathway involves nuclear hormone receptors activated by fatty acids and their derivatives; a study suggested that genetic variations in this pathway gene may contribute to pancreatic cancer susceptibility (Liu et al., 2020). This evidence concerns the gene NR0B1 and familial pancreatic carcinoma.